Clinical trial
Evaluation of the Impact of Direct Conversation With Patients in the Compliance With the "Split-dose" Regimen Preparation for Colonoscopy Scheduled in the First Part of the Morning
NCT02638558 is registered in ClinicalTrials.gov with Valduce Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of Direct Conversation With Patients in the Compliance With the "Split-dose" Regimen Preparation for Colonoscopy Scheduled in the First Part of the Morning
- Lead sponsor
- Valduce Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- June 30, 2016
- Enrollment
- 286 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colonoscopy preparation acceptance